Cerebral water content mapping in cirrhosis patients with and without manifest HE
Sign Up to like & getrecommendations! Published in 2019 at "Metabolic Brain Disease"
DOI: 10.1007/s11011-019-00427-y
Abstract: Hepatic encephalopathy (HE) is a frequent and debilitating complication of cirrhosis and its pathogenesis is not definitively clarified. Recent hypotheses focus on the possible existence of low-grade cerebral edema due to accumulation of osmolytes secondary… read more here.
Keywords: cirrhosis patients; cerebral water; cirrhosis; water content ... See more keywords
Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective.
Sign Up to like & getrecommendations! Published in 2022 at "Annals of hepatology"
DOI: 10.1016/j.aohep.2022.100673
Abstract: INTRODUCTION AND OBJECTIVES . Liver Cirrhosis is a major public health issue associated with high morbidity and mortality. The ANSWER trial showed that long-term human albumin (LTA) infusions led to significant reduction of complications and… read more here.
Keywords: albumin; cirrhosis; cirrhosis patients; cost ... See more keywords
Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
Sign Up to like & getrecommendations! Published in 2021 at "Clinics and research in hepatology and gastroenterology"
DOI: 10.1016/j.clinre.2020.11.013
Abstract: OBJECTIVE α-fetoprotein is often used in the diagnosis of hepatocellular carcinoma (HCC). However, there are currently less efficient and highly specific biomarkers to distinguish AFP-negative HCC from liver cirrhosis (LC) patients. PATIENTS AND METHODS We… read more here.
Keywords: cirrhosis patients; afp negative; hcc; negative hcc ... See more keywords
Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of clinical and experimental hepatology"
DOI: 10.1016/j.jceh.2019.01.005
Abstract: Background & aims Cirrhosis is a leading cause of morbidity and mortality in the United States. Early readmission to the hospital after discharge increases the clinical and economic burden of cirrhosis patients. We aim to… read more here.
Keywords: cirrhosis patients; hospital readmission; readmission; hepatic encephalopathy ... See more keywords
Factors determining the mortality in cirrhosis patients with invasive candidiasis: a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Medical mycology"
DOI: 10.1093/mmy/myab069
Abstract: The impact of invasive candidiasis (IC) on the outcomes in the non-conventional high-risk cirrhosis population is poorly characterized. Therefore, we reviewed the outcomes and their influencing factors in cirrhosis patients with IC. PubMed, Embase, Ovid,… read more here.
Keywords: cirrhosis patients; invasive candidiasis; high mortality; cirrhosis ... See more keywords
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "BioMed Research International"
DOI: 10.1155/2017/5358615
Abstract: The early prediction values of diagnostic markers for hepatocellular carcinoma (HCC) are still unclear at present. This study evaluated the prediction value of ten serum markers in HCC. A total of 109 cases of hepatic… read more here.
Keywords: cirrhosis patients; serum markers; hepatic cirrhosis; early prediction ... See more keywords
A Systematic Review and Meta-Analysis of Safety and Efficacy for Pre-Procedural Use of Thrombopoietin Receptor Agonists in Hepatic Cirrhosis Patients
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-132063
Abstract: Introduction Thrombocytopenia is common in liver cirrhosis patients, which often complicates with patients' frequent issue with gastrointestinal bleeding and procedural needs. Based on biologic understanding of decreased thrombopoietin(TPO) level in liver cirrhosis patients, use of… read more here.
Keywords: cirrhosis patients; risk; use; analysis ... See more keywords
Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System
Sign Up to like & getrecommendations! Published in 2018 at "BMC Medical Research Methodology"
DOI: 10.1186/s12874-017-0458-6
Abstract: BackgroundHepatocellular carcinoma (HCC) has limited treatment options in patients with advanced stage disease and early detection of HCC through surveillance programs is a key component towards reducing mortality. The current practice guidelines recommend that high-risk… read more here.
Keywords: cirrhosis patients; hcc; screening approaches; cohort ... See more keywords
An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.716869
Abstract: Hepatitis C virus (HCV)-related cirrhosis leads to a heavy global burden of disease. Clinical risk stratification in HCV-related compensated cirrhosis remains a major challenge. Here, we aim to develop a signature comprised of immune-related genes… read more here.
Keywords: cirrhosis patients; hcv related; cirrhosis; signature ... See more keywords
Impact of Vaptans on Clinical Outcomes in Cirrhosis Patients: A Meta-Analysis of Randomized Controlled Trials
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.01365
Abstract: Background: Vaptans have been confirmed to mobilize ascites and improve hyponatremia in cirrhosis patients. However, the effects of vaptans on all-cause mortality, ascites-related complications, and adverse events in cirrhosis patients have not been fully determined.… read more here.
Keywords: cirrhosis patients; impact vaptans; cirrhosis; vaptans clinical ... See more keywords
Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10123040
Abstract: (1) Background: Hepatic encephalopathy (HE) is a common complication in cirrhosis patients, and recently, clinical evidence indicates that a higher risk of HE is associated with the usage of proton pump inhibitors. However, the cortical… read more here.
Keywords: patients treated; proton pump; cirrhosis patients; pump inhibitors ... See more keywords